Regentis Biomaterials Ltd. (RGNT) — Financial Flexibility Index
Regentis Biomaterials Ltd. (RGNT) has a Financial Flexibility Index of -0.48x as of December 2025. Free cash flow of $-1.38 Million (operating CF $-1.38 Million minus capex $0.00) represents 0% of total liabilities ($2.87 Million). Read RGNT liabilities breakdown for a breakdown of total debt and financial obligations.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Regentis Biomaterials Ltd. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Regentis Biomaterials Ltd. across 4 annual periods. Explore how well can Regentis Biomaterials Ltd. service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Financial Flexibility Index for Regentis Biomaterials Ltd. (2022–2025)
Year-by-year free cash flow to debt coverage for Regentis Biomaterials Ltd.. For the full cash flow conversion analysis, see Regentis Biomaterials Ltd. (RGNT) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.48x | $-1.38 Million | $-1.38 Million | $2.87 Million | ▼ -3003.9% |
| 2024 | -0.02x | $-641.00K | $-641.00K | $41.59 Million | ▲ +41.5% |
| 2023 | -0.03x | $-1.22 Million | $-1.22 Million | $46.27 Million | ▲ +23.2% |
| 2022 | -0.03x | $-1.50 Million | $-1.50 Million | $43.78 Million | — |